Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Poschel

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Immunology Letters|June 26, 2024
In vitro antibody-mediated SARS-CoV-2 infection suppression through human ACE2 receptor blockadePriscilla S Redd, Alyssa D Merting, John D Klement, et al.
Journal of Medicinal Chemistry|May 1, 1984
Amnesia-reversal activity of a series of N-[(disubstituted-amino)alkyl] -2-oxo-1-pyrrolidineacetamides, including pramiracetamD E Butler, I C Nordin, Y J L'Italien, et al.
Cancers|March 6, 2021
Osteopontin Blockade Immunotherapy Increases Cytotoxic T Lymphocyte Lytic Activity and Suppresses Colon Tumor ProgressionJohn D Klement, Dakota B Poschel, Chunwan Lu, et al.
Cells|January 21, 2023
IRF8 Regulates Intrinsic Ferroptosis through Repressing p53 Expression to Maintain Tumor Cell Sensitivity to Cytotoxic T LymphocytesDakota B Poschel, Mercy Kehinde-Ige, John D Klement, et al.
Molecular Cancer Therapeutics|June 15, 2026
H3K9me3 regulates IFNγlo Tex cell differentiation to promote colon tumor liver metastasisKendra Fick, Yang Zhao, Zainab Tiamiyu, et al.
Journal for Immunotherapy of Cancer|July 30, 2021
WDR5-H3K4me3 epigenetic axis regulates OPN expression to compensate PD-L1 function to promote pancreatic cancer immune escapeChunwan Lu, Zhuoqi Liu, John D Klement, et al.
Journal of Medicinal Chemistry|March 1, 1987
Amnesia-reversal activity of a series of cyclic imidesD E Butler, J D Leonard, B W Caprathe, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2026
B cell-intrinsic IRF8 transcriptionally reprograms antigen presentation to sustain CD8⁺ T cell antitumor immunityZainab Tiamiyu, Dakota B Poschel, Richa Rashmi, et al.
Journal of Medicinal Chemistry|May 1, 1985
1-[3-(Diarylamino)propyl]piperidines and related compounds, potential antipsychotic agents with low cataleptogenic profilesL D Wise, I C Pattison, D E Butler, et al.
Oncogene|August 26, 2025
Slc7a5 promotes T cell anti-tumor immunity through sustaining cytotoxic T lymphocyte effector functionChunwan Lu, Liyan Liang, Yanmin Wu, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Immunology Letters|June 26, 2024
In vitro antibody-mediated SARS-CoV-2 infection suppression through human ACE2 receptor blockadePriscilla S Redd, Alyssa D Merting, John D Klement, et al.
Journal of Medicinal Chemistry|May 1, 1984
Amnesia-reversal activity of a series of N-[(disubstituted-amino)alkyl] -2-oxo-1-pyrrolidineacetamides, including pramiracetamD E Butler, I C Nordin, Y J L'Italien, et al.
Cancers|March 6, 2021
Osteopontin Blockade Immunotherapy Increases Cytotoxic T Lymphocyte Lytic Activity and Suppresses Colon Tumor ProgressionJohn D Klement, Dakota B Poschel, Chunwan Lu, et al.
Cells|January 21, 2023
IRF8 Regulates Intrinsic Ferroptosis through Repressing p53 Expression to Maintain Tumor Cell Sensitivity to Cytotoxic T LymphocytesDakota B Poschel, Mercy Kehinde-Ige, John D Klement, et al.
Molecular Cancer Therapeutics|June 15, 2026
H3K9me3 regulates IFNγlo Tex cell differentiation to promote colon tumor liver metastasisKendra Fick, Yang Zhao, Zainab Tiamiyu, et al.
Journal for Immunotherapy of Cancer|July 30, 2021
WDR5-H3K4me3 epigenetic axis regulates OPN expression to compensate PD-L1 function to promote pancreatic cancer immune escapeChunwan Lu, Zhuoqi Liu, John D Klement, et al.
Journal of Medicinal Chemistry|March 1, 1987
Amnesia-reversal activity of a series of cyclic imidesD E Butler, J D Leonard, B W Caprathe, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2026
B cell-intrinsic IRF8 transcriptionally reprograms antigen presentation to sustain CD8⁺ T cell antitumor immunityZainab Tiamiyu, Dakota B Poschel, Richa Rashmi, et al.
Journal of Medicinal Chemistry|May 1, 1985
1-[3-(Diarylamino)propyl]piperidines and related compounds, potential antipsychotic agents with low cataleptogenic profilesL D Wise, I C Pattison, D E Butler, et al.
Oncogene|August 26, 2025
Slc7a5 promotes T cell anti-tumor immunity through sustaining cytotoxic T lymphocyte effector functionChunwan Lu, Liyan Liang, Yanmin Wu, et al.
Pageof 4